AbbVie ABBV reported second-quarter earnings of $2.26 per share, which beat the analyst consensus estimate of $2.20. This is a 13% increase over earnings of $2 per share from the same period last year.
The company reported quarterly sales of $8.255 billion which beat the analyst consensus estimate of $8.1 billion. This is a 0.04% decrease over sales of $8.258 billion the same period last year.
AbbVie raised fiscal year 2019 EPS guidance from $8.73-$8.83 to $8.82-$8.92 versus a $8.82 estimate.
AbbVie shares were trading up 2.3% at $68.21 in Friday’s pre-market session. The stock has a 52-week high of $100.23 and a 52-week low of $65.06.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
